NYSE · Healthcare
MYOMO, INC. (MYO)
As-reported financials and recent SEC filings for MYOMO, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$40.9M
Net income
$-15.6M
Net margin
-38.1%
Diluted EPS
$-0.37
ROE
-136.6%
P/E (TTM)
—
Market cap
—
Debt / equity
1.0×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $40.9M | $32.6M | $19.2M | $15.6M | $13.9M |
| Gross profit | $26.9M | $23.2M | $13.2M | $10.3M | $10.3M |
| Operating income | $-14.4M | $-6.2M | $-8.2M | $-10.7M | $-10.3M |
| Net income | $-15.6M | $-6.2M | $-8.1M | $-10.7M | $-10.4M |
| Diluted EPS | $-0.37 | $-0.16 | $-0.28 | $-0.38 | $-0.47 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K/A2026-06-29
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →42026-06-26
View on EDGAR →8-K2026-06-26
View on EDGAR →Largest Healthcare peers
Go deeper on MYO
Search MYOMO, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.